ASND icon

Ascendis Pharma
ASND

Overview Fund Activity

31 hedge funds and large institutions have $416M invested in Ascendis Pharma in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 2 closing their positions.

Holders
31
Holders Change
+9
Holders Change %
+40.91%
% of All Funds
0.78%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.18%
New
11
Increased
13
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RCM
1
RA Capital Management
Massachusetts
$109M
2
DM
2
Deerfield Management
New York
$21.3M
3
EC
3
EcoR1 Capital
California
$19.7M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$63.8M
5
O
5
OrbiMed
New York
$55M

Top Sellers

1
SCM
1
Sio Capital Management
New York
$0
2
JHIU
2
Janus Henderson Investors US
Colorado
$12M
3
NC
3
Nexthera Capital
New York
$2.02M
4
CS
4
Credit Suisse
Switzerland
$0
5
UBS Group
5
UBS Group
Switzerland
$4K
Name Holding Trade Value Shares
Change 		Shares
Change %
Wells Fargo
26
Wells Fargo
California
$106K +$106K +5,247 New
Bank of America
27
Bank of America
North Carolina
$88K +$22.4K +1,100 +34%
Morgan Stanley
28
Morgan Stanley
New York
$13K +$13K +662 New
TRCT
29
Tower Research Capital (TRC)
New York
$12K -$4.53K -230 -27%
UBS Group
30
UBS Group
Switzerland
$4K -$14.4K -718 -78%
US Bancorp
31
US Bancorp
Minnesota
$2K +$2K +76 New
SCM
32
Sio Capital Management
New York
– -$2.26M -112,497 Closed
CS
33
Credit Suisse
Switzerland
– -$302K -15,031 Closed
1
2